Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2008-10-15
pubmed:abstractText
The aim of this randomized study was to evaluate the efficacy of cefozopran monotherapy and piperacillin-tazobactam plus ceftazidime (PIPC/TAZ + CAZ) combination therapy in pediatric neutropenic patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1545-5017
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
51
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
774-7
pubmed:dateRevised
2009-1-12
pubmed:meshHeading
pubmed-meshheading:18661495-Adolescent, pubmed-meshheading:18661495-Anti-Bacterial Agents, pubmed-meshheading:18661495-Ceftazidime, pubmed-meshheading:18661495-Cephalosporins, pubmed-meshheading:18661495-Child, pubmed-meshheading:18661495-Child, Preschool, pubmed-meshheading:18661495-Drug Therapy, Combination, pubmed-meshheading:18661495-Female, pubmed-meshheading:18661495-Hematologic Neoplasms, pubmed-meshheading:18661495-Humans, pubmed-meshheading:18661495-Infant, pubmed-meshheading:18661495-Infant, Newborn, pubmed-meshheading:18661495-Male, pubmed-meshheading:18661495-Neutropenia, pubmed-meshheading:18661495-Penicillanic Acid, pubmed-meshheading:18661495-Piperacillin, pubmed-meshheading:18661495-Prognosis, pubmed-meshheading:18661495-Prospective Studies, pubmed-meshheading:18661495-Survival Rate, pubmed-meshheading:18661495-beta-Lactamases
pubmed:year
2008
pubmed:articleTitle
A prospective, randomized study comparing cefozopran with piperacillin-tazobactam plus ceftazidime as empirical therapy for febrile neutropenia in children with hematological disorders.
pubmed:affiliation
Department of Pediatrics, Sapporo Hokuyu Hospital, Sapporo, Japan. t-satou@jacls.jp
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Multicenter Study